SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $7,219,000 | -5.5% | 77,800 | -30.0% | 0.07% | -13.8% |
| Q3 2014 | $7,641,000 | -34.4% | 111,100 | 0.0% | 0.08% | -41.6% |
| Q2 2014 | $11,643,000 | +26.3% | 111,100 | 0.0% | 0.14% | +21.2% |
| Q1 2014 | $9,218,000 | +9.6% | 111,100 | -14.5% | 0.11% | -8.9% |
| Q4 2013 | $8,414,000 | +2.1% | 130,000 | 0.0% | 0.12% | -15.6% |
| Q3 2013 | $8,241,000 | – | 130,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|